Lunai Bioworks
New York
About Lunai Bioworks
Renovaro Biosciences, Inc. is a biotechnology company dedicated to the development of advanced allogenic cell and gene therapies to promote stronger immune system responses, potentially leading to long-term or life-long cancer remission in some of the deadliest cancers, as well as the treatment or cure of serious infectious diseases such as HIV and Hepatitis B virus (HBV).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $199.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2026)
- Ticker: nasdaq:RENB
- Website: renovarogroup.com
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/lunai-bioworks-10483 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.